HALO
#968
Halozyme Therapeutics, Inc. - Common Stock
76.1 1 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.12%
Monthly Change
+8.54%
6 month change
+4.53%
Year Change
+13.94%
Previous Close
76.2 0
Open
76.1 1
Low
76.1 1
High
76.1 1
Volume
209
Financials
- Market Capitalization 9.03 B
- Employee 423
- Founded 1998
- CEO Helen I. Torley
- Website www.halozyme.com
- Headquarter Delaware, United States
- FIGI BBG000CZ8W54
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
26.29
Price to sales ratio
5.97
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 959 |  CORT Corcept Therapeutics Incorporated - Common Stock | 85.90 USD | -6.51% | -6.98% | +3.61% | +17.08% | 9.22 B USD | ||
| 967 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 110.40 USD | -7.50% | -4.18% | +27.97% | +86.80% | 9.08 B USD | ||
| 983 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.67 USD | +0.11% | +0.11% | +141.96% | +103.58% | 8.82 B USD | ||
| 987 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 314.56 USD | -3.21% | -0.17% | +16.12% | +482.63% | 8.77 B USD |
Frequently asked questions about Halozyme Therapeutics, Inc. - Common Stock
What is the Halozyme Therapeutics, Inc. - Common Stock stock price today?
The current price of Halozyme Therapeutics, Inc. - Common Stock (HALO) is 76.11. Over the past 24 hours, the stock has changed by -0.12%. Follow the HALO chart for real-time price dynamics.
What is the stock ticker of Halozyme Therapeutics, Inc. - Common Stock?
Halozyme Therapeutics, Inc. - Common Stock trades under the ticker HALO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Halozyme Therapeutics, Inc. - Common Stock stock going up?
HALO has changed by -6.56% over the last week, +8.54% over the last month, and +13.94% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Halozyme Therapeutics, Inc. - Common Stock net income for the last quarter?
Halozyme Therapeutics, Inc. - Common Stock reported net income of 150.05 M for the last quarter. The previous quarter showed -141.59 M, which means net income changed by +205.97%.
How many employees does Halozyme Therapeutics, Inc. - Common Stock have?
As of the latest available data, Halozyme Therapeutics, Inc. - Common Stock has 423 employees. Workforce size can provide additional context about the company's scale and operations.
What is Halozyme Therapeutics, Inc. - Common Stock EBITDA?
Halozyme Therapeutics, Inc. - Common Stock EBITDA is 188.74 M, and its EBITDA margin is 50.1%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Halozyme Therapeutics, Inc. - Common Stock stock?
You can buy Halozyme Therapeutics, Inc. - Common Stock (HALO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Halozyme Therapeutics, Inc. - Common Stock stock?
Investing in Halozyme Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the HALO chart and related analysis on metatrader.com as part of your research.